Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Olivier Jules van Not"'
Autor:
Melissa Melanie de Meza, Marion Stevense, Geke A. P. Hospers, Ellen Kapiteijn, Michel W.J.M. Wouters, Rozemarijn S. van Rijn, Han J. Bonenkamp, Willeke A. M. Blokx, Christian U. Blank, Karijn P M Suijkerbuijk, Marye Boers-Sonderen, Jan Willem B. de Groot, Djura Piersma, Astrid Aplonia Maria Van Der Veldt, John B. A. G. Haanen, Olivier Jules van Not, Franchette W P J van den Berkmortel, Maureen J.B. Aarts, Alfonsus J. M. van den Eertwegh, Gerard Vreugdenhil
Publikováno v:
Journal of Clinical Oncology, 39(15). AMER SOC CLINICAL ONCOLOGY
e21527 Background: Recent data in Japanese patients suggest poor outcomes for anti-PD1 in acral melanoma (AM), with no data available on combination treatment. The objective of this study was to analyze the efficacy of anti-PD1 monotherapy and anti-P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::840ad9c83e228f491981a594250a9554
https://research.rug.nl/en/publications/7014bd9c-124b-43f8-a8d3-c06dd8f4183f
https://research.rug.nl/en/publications/7014bd9c-124b-43f8-a8d3-c06dd8f4183f
Autor:
Christian U. Blank, Maureen J.B. Aarts, Djura Piersma, Karijn P M Suijkerbuijk, Franchette W P J van den Berkmortel, Michel W.J.M. Wouters, Geke A. P. Hospers, Astrid Aplonia Maria Van Der Veldt, Anne M.L. Jansen, Han J. Bonenkamp, Marye Boers-Sonderen, Jan Willem B. de Groot, John B. A. G. Haanen, Rozemarijn S. van Rijn, Alfonsus J. M. van den Eertwegh, Marion Stevense, Ellen Kapiteijn, Willeke A. M. Blokx, Gerard Vreugdenhil, Olivier Jules van Not
Publikováno v:
Journal of Clinical Oncology, 39(15). AMER SOC CLINICAL ONCOLOGY
9558 Background: The ability to analyze tumor mutation profiles has altered the oncology treatment landscape over the past decades. However, little is known about the effect of specific gene mutations on the response to immune checkpoint inhibitors (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed303bc2f6f7ffdcf827c043b9870b03
https://research.rug.nl/en/publications/4d75de12-c696-44ea-b920-33c203f7113a
https://research.rug.nl/en/publications/4d75de12-c696-44ea-b920-33c203f7113a
Autor:
Melissa Melanie de Meza, Willeke Blokx, Han J. Bonenkamp, Christian U. Blank, Maureen J.B. Aarts, Franchette Van Den Berkmortel, Marye J. Boers-Sonderen, Jan Willem de Groot, John B. A. G. Haanen, Geke Hospers, Ellen Kapiteijn, Olivier Jules van Not, Djura Piersma, Rozemarijn Van Rijn, Marion Stevense - den Boer, Astrid Aplonia Maria Van Der Veldt, Gerard Vreugdenhil, Alfonsus Johannes Maria van den Eertwegh, Karijn Suijkerbuijk, Michel W.J.M. Wouters
Publikováno v:
Journal of Clinical Oncology. 40:9577-9577
9577 Background: Few clinical trials address the efficacy of adjuvant systemic treatment in patients with ITM. This study describes the efficacy of adjuvant systemic therapy of ITM patients beyond the clinical trial setting. Methods: All stage III ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f75caab572e5753e2db6ab16715a32d5
https://doi.org/10.1200/jco.2022.40.16_suppl.9577
https://doi.org/10.1200/jco.2022.40.16_suppl.9577
Autor:
Olivier Jules van Not, Rik Jasper Verheijden, Alfonsus Johannes Maria van den Eertwegh, John B. A. G. Haanen, Christian U. Blank, Maureen J.B. Aarts, Franchette Van Den Berkmortel, Jan Willem de Groot, Geke Hospers, Ellen Kapiteijn, Melissa Melanie de Meza, Djura Piersma, Rozemarijn Van Rijn, Marion Stevense - den Boer, Astrid Aplonia Maria Van Der Veldt, Gerard Vreugdenhil, Marye J. Boers-Sonderen, Willeke Blokx, Michel W.J.M. Wouters, Karijn Suijkerbuijk
Publikováno v:
Journal of Clinical Oncology. 40:9546-9546
9546 Background: Management of checkpoint-inhibitor-induced immune-related adverse events (irAEs) is primarily based on expert opinion. Recent studies have suggested detrimental effects of immunosuppressive treatment with anti-TNF on checkpoint-inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b82896604946daa0bfc4e47f29e45232
https://doi.org/10.1200/jco.2022.40.16_suppl.9546
https://doi.org/10.1200/jco.2022.40.16_suppl.9546